Publications by authors named "Frederick Hayden"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

753

Total Likes

203

Extended Reach

550,683

Social Features

139
I
Influenza A(H3N2) Subclade K Virus: Threat and Response.
Maria Zambon, Frederick G Hayden

JAMA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction and Update: Advances in Influenza Therapeutics.
Frederick G Hayden, Richard J Whitley

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.
Remy Pasco, Frederick G Hayden, Lauren Ancel Meyers

J Infect Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Susanna K Tan, Deborah Cebrik, David Plotnik, Maria L Agostini, Keith Boundy, Frederick G Hayden

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Favipiravir Exposure and Pharmacodynamic Effects in Adult Outpatients With Acute Influenza.
Frederick G Hayden, Robert P Lenk, Carol Epstein, Lih Lisa Kang

J Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Effectiveness of Baloxavir Marboxil and Oseltamivir Treatment in Reducing Household Transmission of Influenza: A Post Hoc Analysis of the BLOCKSTONE Trial.
Hideyuki Ikematsu, Takamichi Baba, Masaya M Saito, Masahiro Kinoshita, Shogo Miyazawa, Frederick G Hayden

Influenza Other Respir Viruses· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Impact of COVID-19 on Agricultural Workers, Guatemala.
Daniel Olson, Diva M Calvimontes, Molly M Lamb, Gerber Guzman, Edgar Barrios, Frederick G Hayden

Emerg Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favipiravir Treatment of Uncomplicated Influenza in Adults: Results of Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Trials.
Frederick G Hayden, Robert P Lenk, Lucille Stonis, Catherine Oldham-Creamer, Lih Lisa Kang

J Infect Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of treatment effect of interferon-β1b and lopinavir-ritonavir in patients with Middle East respiratory syndrome by cytokine levels.
Yaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, Mashan L Abdullah, Haya A Aljami, Frederick G Hayden

Sci Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing Influenza Virus Transmission: The Potential Value of Antiviral Treatment.
Frederick G Hayden, Jason Asher, Benjamin J Cowling, Aeron C Hurt, Hideyuki Ikematsu

Clin Infect Dis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study.
Daniel Olson, Diva M Calvimontes, Molly M Lamb, Gerber Guzman, Edgar Barrios, Frederick G Hayden

medRxiv· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment - Meeting report from an isirv-WHO virtual conference.
Jennifer L McKimm-Breschkin, Alan J Hay, Bin Cao, Rebecca J Cox, Jake Dunning, Frederick G Hayden

Antiviral Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group.
Michael G Ison, Frederick G Hayden, Alan J Hay, Larisa V Gubareva, Elena A Govorkova

Antiviral Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit.
Matthew D Hall, James M Anderson, Annaliesa Anderson, David Baker, Jay Bradner, Frederick G Hayden

J Infect Dis· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baloxavir Treatment in Adolescents With Acute Influenza: Subgroup Analysis From the CAPSTONE-1 Trial.
Simon Portsmouth, Frederick G Hayden, Keiko Kawaguchi, Toru Ishibashi, Masahiro Kinoshita

J Pediatric Infect Dis Soc· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, Morten Hylander Møller, Marlies Ostermann, Frederick G Hayden

Crit Care Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2a, open-label, dose-escalating, multi-center pharmacokinetic study of favipiravir (T-705) in combination with oseltamivir in patients with severe influenza.
Yeming Wang, Wu Zhong, Alex Salam, Joel Tarning, Qingyuan Zhan, Frederick G Hayden

EBioMedicine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.
Michael G Ison, Simon Portsmouth, Yuki Yoshida, Takao Shishido, Melissa Mitchener, Frederick G Hayden

Lancet Infect Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis.
Jiuyang Xu, Chaolin Huang, Guohui Fan, Zhibo Liu, Lianhan Shang, Frederick G Hayden

Front Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon Beta-1b and Lopinavir-Ritonavir for Middle East Respiratory Syndrome.
Yaseen M Arabi, Ayed Y Asiri, Abdullah M Assiri, Hanan H Balkhy, Ali Al Bshabshe, Frederick G Hayden

N Engl J Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
Bin Cao, Frederick G Hayden

Lancet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
Hideyuki Ikematsu, Frederick G Hayden, Keiko Kawaguchi, Masahiro Kinoshita, Menno D de Jong

N Engl J Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Frederick G Hayden

Lancet· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
Yeming Wang, Fei Zhou, Dingyu Zhang, Jianping Zhao, Ronghui Du, Frederick G Hayden

Trials· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis